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Abstract 
Exhaled breath samples had the highest positive rate (26.9%, n=52), followed by surface 
swabs (5.4%, n=242), and air samples (3.8%, n=26). COVID-19 patients recruited in Beijing 
exhaled millions of SARS-CoV-2 RNA copies into the air per hour. Exhaled breath emission 
may play an important role in the COVID-19 transmission.  
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Introduction 
The COVID-19 pandemic has left a major mark on human history. Global efforts to 
intervene the spread are accelerating. However, scientific information on the major routes of 
COVID-19 transmission is required. Analysis of environmental samples provides clues [1-4]. 
Notably, SARS-CoV-2 has been detected in air [2-4], on ventilation fans [1] and hospital 
floors [1,4]. Surface swabs from keyboards, cell phones, and patients’ hands have also tested 
positive [1]. Other studies have shown that aerosolized SARS-CoV-2 not only survives on 
various surfaces for sustained periods of time [5], but also remains viable in the air for up to 3 
hours [6]. Despite these rapid developments, the key COVID-19 transmission routes still 
remain debated [7], and evidence is extremely sparse on how SARS-CoV-2 is emitted into 
the air. Recently, scientists called for a recognition of airborne transmission of COVID-19 
[8], and World Health Organization (WHO) made a change to the guideline accordingly, i.e., 
not excluding airborne transmission in crowed and closed settings. Here, we mainly 
investigated the breath emission of SARS-CoV-2 from 49 COVID-19 patients recruited in 
Beijing in addition to its environmental detection.  
 
Methods 
We recruited a total of 76 subjects, including 57 patients with COVID-19, four patients 
without COVID-19 from Hospital A and Hospital B, and 15 healthy subjects in Beijing (Table 
S1). Exhaled breath condensate (EBC) samples were collected from 20 imported COVID-19 
patients from Canada, France, Iran, Italy, Japan, Spain, Thailand, United Kingdom, United 
States, and 29 local cases from Beijing (Table S2). Fig. S1 and Fig. S2 show the intensive care 
unit (ICU) and general ward floor settings of Hospital A, respectively.  EBC samples were 
collected using a BioScreen device developed by Peking University (Fig S3). A total of 52 EBC 
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samples were collected from 49 COVID-19 patients (Table S2). EBC samples were also 
collected from 15 healthy subjects as controls. Twenty-six air samples were taken using two 
impingers (Fig S4; Table S3) as described in Supporting Information. A total of 242 surface 
swabs (10 or 25 cm2) in quarantine hotels and hospitals or personal items from COVID-19 
patients were obtained using wet cotton swabs (Table S4). All the samples collected were 
analyzed using RT-PCR (Roche 96 fluorescence qPCR instrument, Roche Molecular Systems, 
Inc., Pleasanton, CA) for SARS-CoV-2 targeting both ORF1ab and N genes using a detection 
kit (Jiangsu Bioperfectus Technologies, Nanjing, China). The quantitative estimates of viral 
loads in all samples were performed using the RNA amplification equation, and 
experimental and calculation details are described in Supporting Information. The ethics 
involving human subjects including the non-invasive collection of exhaled breath 
condensate samples was waived due to the urgency of the infectious disease outbreak, and 
approved by the Ethics Committee of the Center for Disease Control and Prevention of 
Chaoyang District of Beijing. 
 
Results 
The overall SARS-CoV-2 positive rate for EBC samples was 26.9% (n=52), while surface 
swabs and air samples had low positive rates of (5.4%, n=242), and (3.8%, n=26), 
respectively (Table 1). Cycle threshold (Ct) values (35.54±3.14) were obtained for each 
positive EBC sample (Table 1). The Ct values for EBC samples varied greatly among the 
patients, with lower values generally detected for earlier disease stages (Table S2). The 
breath emission rate was estimated to be from 1.03x105 to 2.25x107 viruses per hour (n=14) 
(Table1). The detection kit had different amplification efficiencies for ORF1ab and N target 
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genes of EBC samples (Table S2). Although EBC samples from two patients (A and B) were 
shown to contain SARS-CoV-2 (Table S2), surface swabs from their cell phones, hands, and 
toilet surfaces were negative for the virus (Table S4). In the ward of patient C, the virus was 
present on the surface of an air ventilation duct entrance that was located below the 
patient’s bed (Video S2). In addition to causing air contamination, the exhaled SARS-CoV-2 
could be partially responsible for the contamination on the surfaces that was observed. 
 
From 26 air samples collected including those using a robot (Video S1), one sample (air-
1) from an unventilated quarantine hotel toilet room was positive (estimated to be 6.07x103 
viruses/m3) (Table 1, Fig. S5, Table S4). Surface swab samples from a pillow case (Swab-1) 
and hands (Swab-2) of patient D who used the toilet room were shown to contain SARS-
CoV-2, but no virus was detected in this patient’s EBC sample which was collected on a 
different date (Fig. S5). Additionally, SARS-CoV-2 was detected on an air ventilation duct 
entrance surface as described above (the duct acted like an air sampler) (Fig S5). These air 
sample data, despite the low positive rate, still show that the air spaces of the hospitals 
housing the COVID-19 patients were contaminated with SARS-CoV-2. 
 
Out of 242 surface swab samples, 13 were positive for SARS-CoV-2 (Table 1, Fig. S6 and 
Table S4). Among the five categories of surfaces, the Toilet pit had the highest SARS-CoV-2 
positive rate (16.7%, n=12), followed by the Hospital floor (12.5%, n=16), the Other surfaces 
(7.4%, n=27), the Patient touching surfaces (4.0%, n=149), and the Medical touching 
surfaces (2.6%, n=38). Cycle threshold (Ct) values (36.38±1.92) were obtained for each 
positive surface swab sample (Table 1; Table S4). The surface-borne viral level was 
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estimated to be from 7.10 x 103 to 1.72 x 105 viruses/cm2 (Table1).  For toilet pit swab 
(Swab-3), the EBC-1 of its associated patient E also tested positive. For the Patient touching 
surfaces group (149 samples), we detected six positives from hands of patient D, a pillow 
case of patient  D, mobile phones of patients F and G, and computer keyboards of patients G 
and H  (Fig. S6; Table S4). Surprisingly, only 2 out of 22 surface swabs from the mobile 
phones of COVID-19 patients tested positive (Fig. S6; Table S4). None of the 26 surface 
swabs collected from handles of various objects appeared positive for the virus (Table S4). 
These observations seemly do not support the widely-held belief that direct transmission by 
contact with surfaces plays a major role in COVID-19 spread. 
 
Discussion 
 
For the first time, we here report that the SARS-CoV-2 is released directly into the air 
via breathing by COVID-19 patients. The detection limit for SARS-CoV-2 by the RT-PCR was 
reported to be approximately 100 RNA copies per µL [9]. Using the equation described in 
Supporting Information, the observed Ct values show that SARS-CoV-2 levels in exhaled 
breath could reach 105-107 copies/m3 if an average breathing rate of 12 L/min is assumed. 
The SARS-CoV-2 breath emission rate is affected by many factors such as disease stage, 
patient activity, and possibly age. We found that the SARS-CoV-2 breath emission rate into 
the air was the highest, up to 105 viruses per min, during the earlier stages of COVID-19. This 
finding was in line with a previous report that the highest SARS-CoV-2 load in throat swabs 
was observed at the time of symptom onset [10]. Another significant discovery from this 
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work is that SARS-CoV-2 emission was not, however, continuous at the same rate, but was 
rather a sporadic event. For example, two EBC samples (EBC-1, EBC-2) collected from the 
same patient E, but on different dates, using the same method returned different test 
results (Table S2).  
 
SARS-CoV-2 has previously been detected in fine particles in hospital air [4]. A peak of 
fluorescence biological particle at around 1 µm was also detected in exhaled breath from 
healthy subjects [11]. The SARS-CoV-2 negative air samples (Fig. S5) may be due to low 
SARS-CoV-2 emissions, virus inactivation by disinfectants, and rapid dilution or removal of 
SARS-CoV-2 by fresh air flow (2.5 m3/min for general hospital wards, Video S2; 12 air 
exchanges per hour for ICU rooms). The SARS-CoV-2 presence in the toilet room air might be 
due to the exhaled virus or the virus aerosolization from the toilet. The spread of COVID-19 
by asymptomatic patients has been also documented [12]. The asymptomatic disease 
carriers do not, generally, cough or sneeze to generate respiratory droplets; thus, the 
observed transmission of the disease has been difficult to explain by respiratory droplet 
transmission, but is rather logical for a fine aerosol route. 
The dominant SARS-CoV-2 transmission routes need to be intervened in order to 
effectively stop the ongoing COVID-19 pandemic. Large respiratory droplets and direct 
contact transmissions are presently cited as major transmission routes for the COVID-19 by 
WHO. In contrast, we show that the surfaces of mobile phones (n=22) and various handles 
(n=35) frequently used by COVID-19 patients presented very low probabilities of SARS-CoV-
2 presence (9.0% and 0%, respectively). Airborne transmission of SARS-CoV-2 has already 
played an important role in documented real-life COVID-19 spread in semi-enclosed 
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environments [7,13]; for example, cluster infection incidents in a choir in Washington State, 
USA [14], and a restaurant in Guangzhou, China [15]. Though we did not study infectivity or 
transmission probability and other virus releasing activities such as talking and singing, our 
study demonstrates that exhaled breath emission plays an important role in SARS-CoV-2 
emission into the air, which could have contributed greatly to the observed airborne cluster 
infections and the ongoing pandemic. Accordingly, measures such as enhanced ventilation 
and the use of face masks are essential to minimize the risk of infection by airborne SARS-
CoV-2.  
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Table 1 Detection of SARS-CoV-2 and its positive rates from 52 EBC samples collected from 
49 COVID-19 patients, 26 air samples, and 242 surface swabs. SARS-CV-2 emission rate or 
concentration level in air or on surface was estimated based on an assumed amplification 
efficiency of 75%; and a RT-PCR detection limit of 100 copies/µL10. Lower and upper bounds 
of virus emission rates or levels corresponded to upper and lower bounds of Ct values. 
 Exhaled breath 
condensate（n=52） 
Air sample 
（n =26） 
Surface swabs（n=242） 
Sample SARS-CoV-2 
positive rate 
14/52 （26.9%） 
 
1/26 (3.8%) 
 
13/242 (5.4%) 
Cycle Threshold (Ct ) 
range* （N or 
ORF1a/b） 
35.54±3.14 
 
38.40 36.38±1.92 
Estimated SARS-CoV-
2 emission rate/level 
(1.03 x 105, 2.25x 107）
viruses/hour 
6.07 x 103 
viruses/m3 
(7.10 x 103, 1.72 x 105) 
viruses/cm2 
* Lower Ct values were used among those of N or ORF1a/b genes for presentation and viral 
estimation. 
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